Literature DB >> 18549688

Fertility preservation in patients with non-oncological conditions.

Yariv Gidoni1, Hananel Holzer, Togas Tulandi, Seang Lin Tan.   

Abstract

In addition to cancers, many non-oncological conditions, including chromosomal abnormalities and autoimmune disorders, are currently treated with gonadotoxic agents that can lead to premature ovarian failure. Because of the young age of some of the women affected by these conditions, attempts to preserve fertility and ovarian function are recommended. To date, retrieval of immature oocytes followed by in-vitro maturation and vitrification has been found to be especially useful for women who cannot undergo ovarian stimulation, or when there is a contraindication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18549688     DOI: 10.1016/s1472-6483(10)60144-7

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  14 in total

1.  Nanoliter droplet vitrification for oocyte cryopreservation.

Authors:  Xiaohui Zhang; Imran Khimji; Lei Shao; Hooman Safaee; Khanjan Desai; Hasan Onur Keles; Umut Atakan Gurkan; Emre Kayaalp; Aida Nureddin; Raymond M Anchan; Richard L Maas; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2011-12-21       Impact factor: 5.307

2.  Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.

Authors:  Jennifer Hirshfeld-Cytron; Clarisa Gracia; Teresa K Woodruff
Journal:  J Womens Health (Larchmt)       Date:  2011-08-09       Impact factor: 2.681

Review 3.  Current approach to fertility preservation by embryo cryopreservation.

Authors:  Giuliano Bedoschi; Kutluk Oktay
Journal:  Fertil Steril       Date:  2013-03-25       Impact factor: 7.329

4.  Sucrose affecting successful transplantation of vitrified-thawed mouse ovarian tissues.

Authors:  Jian-Min Zhang; Lin-Xia Li; Xue-Lian Liu; Yi-Xia Yang; Xiao-Ping Wan
Journal:  J Assist Reprod Genet       Date:  2009-02-10       Impact factor: 3.412

5.  Quality and functionality of human ovarian tissue after cryopreservation using an original slow freezing procedure.

Authors:  Sandra Sanfilippo; Michel Canis; Sergio Romero; Benoît Sion; Pierre Déchelotte; Jean-Luc Pouly; Laurent Janny; Johan Smitz; Florence Brugnon
Journal:  J Assist Reprod Genet       Date:  2012-12-22       Impact factor: 3.412

Review 6.  Concise review: fertility preservation: an update.

Authors:  Clara González; Montserrat Boada; Marta Devesa; Anna Veiga
Journal:  Stem Cells Transl Med       Date:  2012-09-07       Impact factor: 6.940

7.  Cryopreservation of human failed-matured oocytes followed by in vitro maturation: vitrification is superior to the slow freezing method.

Authors:  ZhiGuo Zhang; Yu Liu; Qiong Xing; Ping Zhou; Yunxia Cao
Journal:  Reprod Biol Endocrinol       Date:  2011-12-12       Impact factor: 5.211

Review 8.  In vitro maturation of human immature oocytes for fertility preservation and research material.

Authors:  Hiromitsu Shirasawa; Yukihiro Terada
Journal:  Reprod Med Biol       Date:  2017-06-18

Review 9.  Orthotopic and heterotopic ovarian tissue transplantation.

Authors:  I Demeestere; P Simon; S Emiliani; A Delbaere; Y Englert
Journal:  Hum Reprod Update       Date:  2009-05-27       Impact factor: 15.610

10.  Developmental potential of human oocytes matured in vitro followed by vitrification and activation.

Authors:  Patrick Imesch; David Scheiner; Min Xie; Daniel Fink; Erwin Macas; Raghvendra Dubey; Bruno Imthurn
Journal:  J Ovarian Res       Date:  2013-04-18       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.